Cardiol Therapeutics Inc. Income Statement

Income Statement Dec2020 Dec2021
Revenue & cost
Revenue -15.45M0.06M
Operating items
Research & Development 7.91M8.67M
Share-based Compensation (IS) 0.46M0.95M
Selling, General & Administrative 7.53M22.24M
Operating Expenses 15.45M30.92M
Non-operating items
Non Operating Investment Income -3.92M
Interest & Investment Income 0.06M0.08M
Other Non Operating Income -0.03M1.51M
Additional items
Shares Outstanding (Weighted Average) 44.01M
EBITDA -15.41M-25.25M